ABOUT BTD
PRODUCT
SOLUTIONS
CONTACT US
Trade Dynamics
From January to May 2026, China's coupling agent (HS Code 30067000) exports performed strongly, reaching approximately $19.95 million, up 28.3% year-on-year, with double-digit growth across all months. Imports remained largely flat at around $4.93 million, up just 0.9%. Exports to the US—the largest market—accounted for 23.4% of total export value but at only $4.48/unit, primarily low-end medical ultrasound coupling gels. Imports, however, are heavily dependent on the US (a dominant 79.7% share) at $42.51/unit—9.5 times the export price. This reveals that China imports high-end ultrasound coupling agents (for OEM integration with advanced imaging equipment) while exporting low-priced products to general markets, forming a classic "low-end export, high-end import" structural trade pattern.
| Month | 2025 | 2026 | YoY Change |
|---|---|---|---|
| Jan | 3,414,762 | 4,357,067 | +27.60% |
| Feb | 2,187,374 | 3,622,619 | +65.61% |
| Mar | 3,454,538 | 3,979,029 | +15.18% |
| Apr | 3,568,110 | 4,107,399 | +15.11% |
| May | 2,920,453 | 3,881,182 | +32.90% |
| Total | 15,545,237 | 19,947,296 | +28.31% |
| Month | 2025 | 2026 | YoY Change |
|---|---|---|---|
| Jan | 1,107,570 | 357,238 | -67.75% |
| Feb | 1,064,555 | 1,469,274 | +38.02% |
| Mar | 1,160,806 | 434,733 | -62.54% |
| Apr | 928,970 | 1,248,127 | +34.35% |
| May | 617,748 | 915,447 | +48.19% |
| Total | 4,879,649 | 4,924,819 | +0.93% |
| Metric | Export | Import | Balance |
|---|---|---|---|
| Value (USD) | 19,947,296 | 4,924,819 | Surplus 15,022,477 |
| Avg Unit Price | ~$6.3 | ~$35.2 | Import price 5.6x higher |
| YoY Growth | +28.31% | +0.93% | — |
Slovakia (unit price $143.56)
UAE (unit price $28.43)
Taiwan, China (unit price $21.97)
USA (1.04M units, 37.6% share)
Australia (145K units)
UK (360K units)
USA (62 transactions)
UK (42 transactions)
Australia (31 transactions)
| Rank | Country/Region | Value (USD) | Quantity | Unit Price | Transactions |
|---|---|---|---|---|---|
| 1 | USA | 4,674,571 | 1,043,629 | $4.48 | 62 |
| 2 | UK | 1,640,918 | 360,641 | $4.55 | 42 |
| 3 | UAE | 950,848 | 33,451 | $28.43 | 16 |
| 4 | Turkey | 720,336 | 75,526 | $9.54 | 23 |
| 5 | Slovakia | 623,773 | 4,345 | $143.56 | 7 |
| 6 | Vietnam | 622,876 | 27,723 | $22.47 | 19 |
| 7 | India | 556,103 | 79,606 | $6.99 | 16 |
| 8 | Australia | 542,264 | 144,865 | $3.74 | 31 |
| 9 | Taiwan, China | 537,515 | 24,469 | $21.97 | 14 |
| 10 | Russia | 497,849 | 57,783 | $8.62 | 29 |
Spain (unit price $656.20)
Hong Kong, China (unit price $398.79)
Germany (unit price $103.96)
USA (83K units, 65.3% share)
Japan (18K units)
Turkey (11K units)
USA (51 transactions)
Japan (34 transactions)
Germany (15 transactions)
| Rank | Country/Region | Value (USD) | Quantity | Unit Price | Transactions |
|---|---|---|---|---|---|
| 1 | USA | 3,524,471 | 82,918 | $42.51 | 51 |
| 2 | Japan | 287,974 | 18,461 | $15.60 | 34 |
| 3 | Turkey | 158,377 | 11,322 | $13.99 | 5 |
| 4 | Spain | 105,648 | 161 | $656.20 | 6 |
| 5 | Germany | 94,810 | 912 | $103.96 | 15 |
| 6 | Hong Kong, China | 63,009 | 158 | $398.79 | 3 |
| 7 | Canada | 53,514 | 1,591 | $33.64 | 1 |
| 8 | Netherlands | 30,207 | 210 | $143.84 | 2 |
| 9 | Denmark | 29,587 | 7,490 | $3.95 | 4 |
| 10 | South Korea | 14,506 | 109 | $133.08 | 6 |
On the export side, the US is China's largest coupling agent buyer at $4.67 million, but the unit price is only $4.48—typical high-volume, low-price products. On the import side, the US is also China's largest supplier at $3.52 million, but at $42.51/unit—9.5 times the export price. This inversion reveals that China exports primarily standard ultrasound gels for general medical use, while importing high-end specialty coupling agents for OEM integration with advanced imaging equipment and hospital-grade professional products.
The US accounts for 79.7% of China's total coupling agent imports—an extremely high market concentration. Any disruption from US suppliers (such as trade policy changes or capacity fluctuations) would severely impact the supply chain for high-end ultrasound equipment components. This heavy dependence on a single source warrants close attention under current international circumstances.
Among the top 10 export destinations, the US ($4.48), UK ($4.55), and Australia ($3.74) represent "high-volume, low-price" mass markets; Slovakia ($143.56), UAE ($28.43), Vietnam ($22.47), and Taiwan ($21.97) are "low-volume, high-price" niche markets. Slovakia in particular, with 4,345 units at $143.56/unit, likely corresponds to small-batch imports of specialty coupling agents for high-end medical equipment maintenance.
Exports to US: $4.67M, 1.04M units, $4.48/unit → Standard ultrasound gels for US medical retail and primary care facilities.
Imports from US: $3.52M, 83K units, $42.51/unit → High-end specialty coupling agents for OEM integration or maintenance replacement with GE, Philips, and Siemens high-end ultrasound equipment. The same country, two entirely different product profiles—reflecting China's position as a "mid-to-low-end manufacturing hub with high-end import dependence" in the global coupling agent value chain.
The UK ($1.64M, 360K units, 42 transactions) and Australia ($0.54M, 145K units, 31 transactions) share common characteristics: unit prices in the $3.7-$4.6 range (slightly higher than the US), high transaction frequency, and fragmented customer base. This indicates imports are driven by small-to-medium distributors and medical retail, representing mature, standardized ultrasound gel markets.
UAE ($28.43), Vietnam ($22.47), and Taiwan ($21.97) have unit prices 6-7 times higher than the average, reflecting demand for higher-quality coupling agents. As a Middle East medical hub, an emerging market for medical device transfer, and a high-end manufacturing cluster respectively, these markets have higher quality requirements and are willing to pay premium prices. They represent opportunities for improving unit prices and profit margins.
Japan ($15.60), Germany ($103.96), Spain ($656.20), and South Korea ($133.08) all export coupling agents to China at extremely high unit prices—likely specialty products for OEM integration with high-end medical equipment. Spain's $656.20/unit for only 161 units indicates ultra-small-batch, highly customized products with exceptional per-unit value. Germany and South Korea similarly exchange minimal quantities for high values, reflecting these countries' technical dominance in specialty coupling agents.
Continued growth in global ultrasound examination demand: Aging populations and primary care expansion are driving routine ultrasound applications
Clear cost advantage of Chinese coupling agents: Chinese ultrasound gels offer overwhelming price-performance advantages compared to Western products
Accelerating healthcare infrastructure in emerging markets: Hospital expansion in Vietnam, Middle East, and Africa is driving ultrasound equipment and consumables procurement
Continued RCEP and Belt & Road dividends: Regional trade facilitation is reducing customs clearance costs
Heavy import dependence for high-end specialty coupling agents: US accounts for 79.7% of imports, creating concentrated OEM supply chain risks
Export focus on low-end products: Average export price ~$6.3 vs import price ~$35.2 indicates low value-added
Trade friction escalation risks: Potential US tariffs on medical device components would affect both exports and imports
Intensifying domestic competition: Low barriers to entry for ultrasound gels mean many small manufacturers compete on price
Emerging market expansion and cost advantages drive continued export growth
Growing high-end ultrasound equipment inventory in China will expand specialty coupling agent imports
Intense low-end gel competition depresses average prices while high-end products maintain premium margins
Concentrated import sources will be difficult to fundamentally change in the short term
Consolidate mature US and UK markets: The US is the largest single market; the UK has high transaction frequency and stable customers—maintain channel relationships
Prioritize high-price UAE/Vietnam/Taiwan markets: Unit prices 5-7x higher than average with relatively accessible entry barriers—key targets for margin improvement
Monitor Central/Eastern Europe and Russia: Slovakia and Russia show higher unit prices; medical device exhibitions offer entry points
Develop high-end specialty coupling agents: Target OEM integration and high-end imaging equipment needs with low-impurity, hypoallergenic products to achieve import substitution
Obtain international medical certifications: FDA 510(k), CE marking, and other international medical market access certifications pave the way for high-end market entry
Reduce US import dependence: Actively engage Japanese and German high-end coupling agent suppliers to diversify import sources and reduce single-supplier risk
Establish domestic R&D for import substitution: Partner with universities and tertiary hospitals to jointly develop formulas and processes for high-end specialty coupling agents
Address trade policy uncertainty: Monitor US medical device component trade policy developments and establish diversified export destinations
Avoid low-end price competition: Low-price competition erodes margins—build differentiation through hypoallergenic formulas, eco-friendly products, and extended-duration variants
China's coupling agent trade data reveals a thought-provoking industry reality: exports consist primarily of low-end ultrasound gels flowing to general medical markets, while imports are dominated by high-end specialty coupling agents serving OEM integration for advanced imaging equipment—a price gap of 9.5 times between the two. The nearly 30% surge in exports reflects China's manufacturing cost-performance advantage, while the heavy US dependence on the import side signals deep supply chain security concerns. For China's coupling agent industry, the opportunity lies in the continued expansion of global markets, while the challenge rests in the technical barriers of high-end specialty products. Promoting domestic substitution of high-end products, obtaining international medical certifications, and diversifying import sources are the necessary paths for the industry's high-quality development.
